Generic Ozempic, Wegovy Prices Drop in Canada

0:00Pattons on ozempic and Wigavy just expired in Canada, back in January, opening the door for generic versions of these blockbuster weight loss drugs. Right now, folks are shelling out $300 to $400 a month because Novo Nordisk held a monopoly. Experts predict cheaper knockoffs could hit shelves by mid-summer. Health Canada is already reviewing nine submissions for generics of semaglutide, the key ingredient in both ozempic for diabetes and WegoV for weight. These meds work by mimicking a gut hormone to steady blood sugar, slow digestion, and make you feel full longer. Doctors like Sanji Sakalingu from Obesity Canada say sky high prices are blocking access to a vital tool against obesity. Patients want these drugs bad, but the cost keys too many on the sidelines. Over in India, generics launched the day Pattons died, with one company selling them for just 19 Canadian dollars a month. Analysts see up to 50 versions flooding that market soon, and India might supply Canada too,

1:01but everything needs health Canada approval first. Companies like Sando's are pushing hard, aiming for a late June launch here alongside Apatex, Tiva, and others in the regulatory queue. Once approved, expect prices to drop big time and transform how we tackle weight issues. I'm Corey with the story, and you've been listening to Vancouver News today. AI-powered local news.